Please login to the form below

Not currently logged in
Email:
Password:

Reimportation

This page shows the latest Reimportation news and features for those working in and with pharma, biotech and healthcare.

GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

In July, the Trump administration  unveiled plans to allow the reimportation of certain drugs from Canada, which the President advanced in December.

Latest news

  • Biologic patent exclusivity scrapped in new US trade deal Biologic patent exclusivity scrapped in new US trade deal

    In July, the Trump administration unveiled plans to allow the reimportation of some drug from Canada into the US, in order to help patients source cheaper medicines.

  • White House unveils plans to reimport medicines from Canada White House unveils plans to reimport medicines from Canada

    HHS secretary Alex Azar. The Trump administration unveiled plans yesterday to allow the reimportation of some drugs from Canada into the US, in order to help patients source cheaper medicines. ... The idea of reimportation from across the border in Canada

  • Tightly restricted

    Cost constraint mechanisms. Administrative and technology-based steps; focus on chronic care and public health; federal drug price negotiation; reimportation; policies to promote generics; cut Medicare payments; public reporting of provider

  • News in brief, May 09, 2007

    Senate will support reimportation to lower drug costs. The US Senate cleared has backed the legalisation of the reimportation of lower-cost prescription drugs from Canada and other countries in order ... Last week, President Bush was reported as likely

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics